SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (358)12/31/2001 11:10:52 AM
From: richardred  Read Replies (3) of 724
 
Rick & Buba-just like to point out a bit of factual info. In this industry the big players have been buyers of late. Fisher has recently bought Cole-Parmer for about 175mil. net. Apogent in Nov. bought Forefront Diagnostics (small 14 mil in sales)Perkin Elmer -just fairly recently completed the acquisition of Packard Biosciences. Becton Dickinson just recently sign to buy Gentest corp(toxicology testing).

IMO-this tells me there are buyers out there, and more acquisitions and consolidations will be likely coming in this area. NBSC just recently made itself more attractive with out results from DGI. This is takeover speculation, but a plus in the main reason I'm in here. The main thing is a return in sales growth, and bottom line improvement. Takeover speculation is an added plus.

RR
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext